EPHX1 and neoplasm: In a xenograft model using Huh7 cells with stable EPHX1 knockdown, both EPHX1 depletion and regorafenib monotherapy inhibited tumor growth, with maximal suppression achieved by combination therapy (Fig. 4A-B).